Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
08/2006
08/30/2006CN1823843A Child ammonia phenol alkyl amine affervescent tablet and its preparation method
08/30/2006CN1823804A Clamycin fast release micropill and its preparation method
08/30/2006CN1823770A Compound Dextromethorphan oral cavity disintegration tablet
08/30/2006CN1823758A Compounds and methods of treating transplant rejection
08/30/2006CN1823752A Soft capsule composition containing acetaminophen
08/30/2006CN1823748A Medicinal preparation of coenzyme Q10 liposome and its preparation technology
08/30/2006CN1823725A Aerosol pharmaceutical compositions
08/30/2006CN1823721A Compounding of peony natural organic compound series tooth paste product and its preparation method
08/30/2006CN1272334C Quinuclidine derivs. as muscarinic M3 receptors ligand and their use
08/30/2006CN1272065C Medicine for treating chronic bronchitis and bronchial asthma
08/30/2006CN1272044C Cordate houttuynia preparation taken through nose and its production process
08/30/2006CN1272032C Medicines for treating acute and chronic pharyngitis
08/30/2006CN1272020C Composition of hypochlorous acid and its applications
08/30/2006CN1272010C Powdery respiratory tonic composition
08/30/2006CN1271996C Medicinal powder injection for respiratory system and preparing method
08/30/2006CN1271993C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof
08/29/2006US7098364 2-(4-amino-3-chloro-5-trifluoromethyl-phenyl)-2-tert-butylaminoethanol hydrochloride; treating asthma and bronchitis
08/29/2006US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors
08/29/2006US7098216 Thiazolopyrimidines useful as TNFα inhibitors
08/29/2006US7098213 three-ring saturated N-heterocyclic compounds in combination with one or more antiviral or other agents; in immunotherapy
08/29/2006US7098212 Piperazine derivatives
08/29/2006US7098209 Phosphodiesterase inhibitors; cardiovascular disorders; erectile dysfunction; hypotensive agents; respiratory system diosrders; chronic obstructive pulmonary disease; congestive heart failure; antihistamines; antiallergens
08/29/2006US7097986 For use in pharmaceutical and diagnostic formulations
08/29/2006US7097985 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis
08/29/2006US7097827 Devices, compositions and methods for the pulmonary delivery of aerosolized medicaments
08/29/2006CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents
08/29/2006CA2277914C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising budesonide
08/29/2006CA2277891C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof
08/29/2006CA2277890C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising formoterol
08/29/2006CA2201785C New carboxylic acid derivatives, their preparation and their use
08/29/2006CA2053585C Antibody production in chinese hamster ovary cells
08/24/2006WO2006088219A1 Il-13 production inhibitor
08/24/2006WO2006088011A1 Inhibitor of plasminogen activator inhibitor-1
08/24/2006WO2006087419A2 A method for administering levosimendan
08/24/2006WO2006087316A1 Pharmaceutical compositions comprising anticholinergics and etiprednol
08/24/2006WO2006087315A1 Novel, long-acting betamimetics for treating respiratory diseases
08/24/2006WO2006087077A2 Hsp90-inhibiting triazole derivatives
08/24/2006WO2006086821A1 ANTISENS MODULATION OF INTEGRIN α4 EXPRESSION
08/24/2006WO2006067600A3 Herbal formulations as cough lozenge
08/24/2006WO2006065746A3 Methods of treating ige-mediated disorders comprising the administration of high concentration anti-ige antibody formulations
08/24/2006WO2006055638A3 Fully human monoclonal antibodies to il-13
08/24/2006WO2006025991A3 Isoindoline compounds and methods of making and using the same
08/24/2006WO2005082413A3 Ciclesonide and glycopyrronium combination
08/24/2006WO2003043627A8 New anti-asthmatic drug (asmakure) from indigenous herbs to cure the disease asthma
08/24/2006US20060190043 Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee
08/24/2006US20060189809 Method for the synthesis of quinoline derivatives
08/24/2006US20060189688 Use of sodium 2-mercaptoethanesulfonate as antiviral agent
08/24/2006US20060189656 Piperidine derivatives and agent comprising the derivative as active ingredient
08/24/2006US20060189652 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; reacting nitrogen heterocyclic compound with carbonylation agent selected from phosgene, diphosgene, triphosgene, aryl chloroformates, aralkyl chloroformates, alkyl chloroformates, cyclization
08/24/2006US20060189650 Novel piperidine derivatives as modulators of chemokine receptor ccr5
08/24/2006US20060189642 Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
08/24/2006US20060189637 Anilinoquinazaolines as protein tyrosine kianse inhibitors
08/24/2006US20060189615 2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
08/24/2006US20060189613 Sulphonamide Compounds that Modulate Chemokine Receptor Activity (CCR4)
08/24/2006US20060189587 Use for budesonide and formoterol
08/24/2006US20060189549 Chalcone derivatives and their use to treat diseases
08/24/2006US20060189483 Metal-containing compositions, preparations and uses
08/24/2006US20060188913 Methods and products for enhancing immune responses using imidazoquinoline compounds
08/24/2006US20060188484 Virus vectors and methods of making and administering the same
08/24/2006US20060188483 Virus vectors and methods of making and administering the same
08/24/2006US20060188472 HAS-active ingredient conjugates
08/24/2006DE4192786B4 Masernvirus-Rekombinanter Pockenvirus-Impfstoff Measles virus recombinant poxvirus vaccine
08/24/2006DE102005007654A1 Neue langwirksame Betamimetika zur Behandlung von Atemwegserkrankungen New long-acting beta-mimetics for the treatment of respiratory disorders
08/24/2006CA2598355A1 Novel, long-acting betamimetics for treating respiratory diseases
08/24/2006CA2598017A1 Triazole derivatives
08/24/2006CA2597942A1 Pharmaceutical compositions comprising anticholinergics and etiprednol
08/24/2006CA2596986A1 Use of il-17f in diagnosis and therapy of airway inflammation
08/24/2006CA2584614A1 Antisense modulation of integrin .alpha.4 expression
08/23/2006EP1693384A2 Functional immunoglobulins against human serum albumin, fragments thereof, library thereof and methods of production thereof
08/23/2006EP1693372A1 Novel Sulfamides and their use as endothelin receptor antagonists
08/23/2006EP1693068A1 Use of M. tuberculosis chaperonin 60.1 for the treatment of arthritis
08/23/2006EP1692267A2 Methods of organ regeneration
08/23/2006EP1691839A1 Combined doses
08/23/2006EP1691783A1 Pre-metered dry powder inhaler for moisture-sensitive medicaments
08/23/2006EP1691782A1 Medical product containing tiotropium
08/23/2006EP1691781A1 Inhalable tiotropium and container therefor
08/23/2006EP1441785A4 Improved method for generating an aerosol
08/23/2006EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases
08/23/2006EP1401445B1 Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
08/23/2006EP1332144B1 Indole derivatives as pde5-inhibitors
08/23/2006EP1329451B1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient
08/23/2006EP1278747B1 Pyrano, piperidino, and thiopyrano compounds and methods of use
08/23/2006EP1198232B1 Urea substituted imidazoquinolines
08/23/2006EP1171452B1 Pyrrolidincarbolylamino cyclic disulfides as vcam-vla4 antagonists
08/23/2006EP1027328B1 Substituted anilides
08/23/2006CN1823063A Quinoline derivatives as phosphodiesterase inhibitors
08/23/2006CN1822828A Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments
08/23/2006CN1822807A Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
08/23/2006CN1820755A Medicinal composition of cefuroxime and ambroxol hydrochloride
08/23/2006CN1820752A Oral liquor slow releasing preparation containing codeine and chlorophenamine and its preparing method
08/23/2006CN1820749A Formula of amoxycillin sodium/ambroxo/ hydrochloride powder injection and its preparing method
08/23/2006CN1820746A Stepronin powder injection and its preparing method
08/23/2006CN1271073C Crystalline anti-cholinergic tiotropium crystal
08/23/2006CN1271054C Urea compounds having muscarinic receptor antagonist activity
08/23/2006CN1270762C Cough stopping and asthma relieving medicine and its preparation
08/23/2006CN1270759C Cocklebur fruit and magnolia flower contained ointment for treating chronic rhinitis and its preparing process
08/23/2006CN1270734C Deal apple chrysanthemum preparation for treating throat disease
08/23/2006CN1270714C Microemulsion preconcentrates containing piperidine substance P antagonist
08/23/2006CN1270709C Tiotropium aerosol inhalant and its preparation method
08/23/2006CN1270702C Intravenous injection liquid of coenzyme Q10, and its prepn. method